SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 		 FORM 10-Q (Amendment No. 1) QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended January 31, 1995 Commission file Number 0-10964 MAXWELL LABORATORIES, INC. 	 Delaware IRS ID# 95-2390133 8888 Balboa Avenue, San Diego, California 92123 Telephone (619) 279-5100 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ] As of February 28, 1995 Registrant had only one class of common stock of which there were 2,674,973 shares outstanding. PART II - OTHER INFORMATION Item 6. Exhibits and Reports on Form 8-K ________________________________ (a) Exhibits ________ Exhibit 27 - Financial Data Schedule (b) Reports on Form 8-K ___________________ No reports on Form 8-K were filed during the quarter ended January 31, 1995. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MAXWELL LABORATORIES, INC. April 26, 1995 Gary J. Davidson Date Gary Davidson, Chief Financial Officer and Authorized Officer